MannKind's Help Puts CTL Closer to Its Cancer Vaccine

Biotech: A Step Toward The Future

By CARLOS MARTINEZ
Staff Reporter

Just three years ago, CTL ImmunoTherapies Inc. was nothing more than a proposal on a piece of paper in John Simard's small Northridge apartment....

Join our Membership to get the full story.


Are you a current Member? Sign In